EPMDA: Edge Perturbation Based Method for miRNA-Disease Association Prediction

Insights

This study introduces EPMDA, a novel method for predicting microRNA-disease associations. EPMDA significantly improves prediction accuracy, aiding disease understanding and treatment strategies.

Area of Science:

  • Genomics
  • Bioinformatics
  • Computational Biology

Background:

  • MicroRNAs (miRNAs) are implicated in numerous human diseases.
  • Accurate prediction of miRNA-disease associations is crucial for understanding disease mechanisms and developing treatments.

Purpose of the Study:

  • To propose a novel edge perturbation-based method (EPMDA) for predicting potential miRNA-disease associations.
  • To enhance the accuracy of identifying relationships between miRNAs and diseases.

Main Methods:

  • Developed a feature vector using structural Hamiltonian information to describe graph edges.
  • Employed a multi-layer perception model trained on extracted features for association prediction.
  • Utilized an edge perturbation approach for enhanced prediction.

Main Results:

  • EPMDA achieved an AUC of 0.9818 in 5-fold cross-validation on the HMDD dataset, outperforming DeepMDA by 3.5%.
  • Achieved an AUC of 0.9371 in leave-one-disease-out cross-validation, surpassing DeepMDA by 7.4%.
  • Case studies confirmed 42, 46, and 41 top-50 predicted miRNAs for three diseases, validating EPMDA's performance.

Conclusions:

  • EPMDA demonstrates superior performance in predicting miRNA-disease associations compared to existing methods.
  • The proposed method offers a valuable tool for advancing research in miRNA-related diseases.
  • Findings support the utility of structural graph information and machine learning in bioinformatics.

Related Concept Videos

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform10:37

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform

We describe the use of a multiplexed high-throughput gene expression platform that quantitates gene expression by barcoding and counting molecules in biological substrates without the need for amplification. We used the platform to quantitate microRNA (miRNA) expression in whole blood in subjects with and without irritable bowel syndrome.
8.7K
miRNA Extraction: A Method to Extract miRNA from Plasma Sample03:59

miRNA Extraction: A Method to Extract miRNA from Plasma Sample

MicroRNAs (miRNAs) are tissue specific, small, non-coding RNAs regulating gene expression, and could represent ideal candidates for early detection of lung cancer. In the featured protocol, we will isolate microRNA from patient blood samples for early lung cancer...
4.4K
mirMachine: A One-Stop Shop for Plant miRNA Annotation06:16

mirMachine: A One-Stop Shop for Plant miRNA Annotation

Herein, we present a new and fully automated miRNA pipeline, mirMachine that 1) can identify known and novel miRNAs more accurately and 2) is fully automated and freely available. Users can now execute a short submission script to run the fully automated mirMachine...
2.9K
Circulating miRNA Extraction: A Method to Isolate miRNA from Plasma Samples Via Organic Extraction and Small RNA Enrichment04:33

Circulating miRNA Extraction: A Method to Isolate miRNA from Plasma Samples Via Organic Extraction and Small RNA Enrichment

This video describes the extraction of circulating microRNA from plasma samples of colorectal cancer patients using organic extraction followed by glass-fiber column enrichment. miRNAs are stable in biological fluids such as serum and plasma, which renders them ideal circulating biomarkers for cancer diagnosis, prognosis, and treatment decision-making and monitoring. This method will help identify new circulating biomarkers capable of predicting clinical outcomes in...
1.6K
Modelling Intratumoral Treatment with miRNA Inhibitors: A Method to Analyze the Effect of miRNA Inhibitors on Tumor Growth in Murine Model04:00

Modelling Intratumoral Treatment with miRNA Inhibitors: A Method to Analyze the Effect of miRNA Inhibitors on Tumor Growth in Murine Model

This video demonstrates the in vivo delivery of miRNA inhibitors as therapeutic agents against tumor growth in orthotopic mouse models. The intratumoral administration of synthetic miRNA inhibitors or antagomiRs allows them to bind and inhibit endogenous miRNAs, thereby causing mRNA upregulation and suppression of tumor...
2.9K
Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models07:01

Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models

Here, we deliver exogenous artificially synthesized miRNA mimics to the kidney via tail vein injection of a nonviral vector and polyethylenimine nanoparticles in several kidney disease mouse models. This led to significant overexpression of target miRNA in the kidney, resulting in inhibited progression of kidney disease in several mouse models.
1.9K